Published in Biull Eksp Biol Med on July 01, 1986
[Novel endogenous dipeptide cycloprolyl-glycine is similar to pyracetam in selectivity of their mnemotropic effect]. Biull Eksp Biol Med (1999) 0.90
[Similarity of cycloprolylglycine to piracetam in antihypoxic and neuroprotective effects]. Eksp Klin Farmakol (2012) 0.87
[Design and synthesis of dipeptide mimetics of brain-derived neurotrophic factor]. Bioorg Khim (2012) 0.86
Further evidence for GABA-ergic mechanisms in the action of benzodiazepines. Arch Int Pharmacodyn Ther (1977) 0.86
Neuroprotective effect of GK-2, a dipeptide mimetic of nerve growth factor, during experimental focal ischemia in middle cerebral artery basin. Bull Exp Biol Med (2011) 0.81
Memory restoring and neuroprotective effects of the proline-containing dipeptide, GVS-111, in a photochemical stroke model. Behav Pharmacol (1999) 0.80
[Identification in the rat brain of cyclo-prolylglycine, a novel endogenous peptide with nootropic activity]. Dokl Akad Nauk (1996) 0.80
[Antagonism of piracetam with proline in relation to mnestic effects]. Biull Eksp Biol Med (1985) 0.79
On some principles of interaction of curare-like agents with acetylcholine receptors of skeletal muscles. J Pharm Pharmacol (1980) 0.79
Neuroprotective and antiamnestic effect of nerve growth factor dipeptide mimetic GK-2 in experimental ischemic infarction of brain cortex. Bull Exp Biol Med (2011) 0.79
[Effect of cocaine molecule fragments on the central nervous system]. Biull Eksp Biol Med (1978) 0.79
[The use of the HPLC method for the quantitative determination of a peptide analog of piracetam with nootropic activity and its main metabolites]. Eksp Klin Farmakol (1996) 0.79
In vitro study of neuroprotective properties of GK-2, a new original nerve growth factor mimetic. Bull Exp Biol Med (2011) 0.79
[The study of procognitive effect of the potential antipsychotic, Dilept and its main metabolite, GZR-125 at the novel objects recognition test in rats]. Eksp Klin Farmakol (2013) 0.79
[Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123]. Eksp Klin Farmakol (2002) 0.78
[Effect of the novel nootropic and neuroprotective dipeptide noopept on the streptozotocin-induced model of sporadic Alzheimer disease in rats]. Eksp Klin Farmakol (2010) 0.78
[Strategy for the development of dipeptide drugs]. Vestn Ross Akad Med Nauk (2011) 0.78
[Dipeptide nootropic agent GVS-111 prevents accumulation of the lipid peroxidation products during immobilization]. Eksp Klin Farmakol (1998) 0.78
[Penetration of catecholamines through the blood-brain barrier]. Biull Eksp Biol Med (1972) 0.77
[The original novel nootropic and neuroprotective agent noopept]. Eksp Klin Farmakol (2003) 0.77
[Preservation of plastic properties of synaptic transmission in long-lasting hippocampal slices under the effects of a peptide analog of piracetam, L-pGlu-D-Ala-NH2]. Biull Eksp Biol Med (1990) 0.77
[Hydrolysis by plasma cholinesterase of complex adamantyl-containing esters]. Farmakol Toksikol (1989) 0.77
The effects of piracetam and its novel peptide analogue GVS-111 on neuronal voltage-gated calcium and potassium channels. Gen Pharmacol (1997) 0.77
The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine. Eur J Drug Metab Pharmacokinet (1997) 0.77
[Neuroprotective activity of the proline-containing dipeptide noopept on the model of brain ischemia induced by the middle cerebral artery occlusion]. Eksp Klin Farmakol (2006) 0.77
[On the mechanism of noopept action: decrease in activity of stress-induced kinases and increase in expression of neutrophines]. Eksp Klin Farmakol (2010) 0.77
[New derivatives of 10,11-dihydro-5H-dibenz[b,f]azepine with antiarrhythmic action]. Pharmazie (1985) 0.77
Antiparkinsonian properties of a nerve growth factor dipeptide mimetic GK-2 in in vivo experiments. Bull Exp Biol Med (2011) 0.77
[Prenatal exposure to sodium oxybutyrate prevents a disorder of general behavior, learning and memory in the progeny of rats subjected to chronic hemic hypoxia]. Eksp Klin Farmakol (1994) 0.77
Endogenous dipeptide cycloprolylglycine shows selective anxiolytic activity in animals with manifest fear reaction. Bull Exp Biol Med (2002) 0.76
[Interstrain differences in the content of excitatory and inhibitory amino acids in the brain of DBA/2J, Balb/c and C57BL/6 mice: characteristics of the effect of a dipeptide antipsychotic drug dilept]. Eksp Klin Farmakol (2008) 0.76
[Neuroprotective effects of a dipeptide mimetic on the GK-2 nerve growth factor in model of permanent common carotid artery occlusion in rats]. Eksp Klin Farmakol (2012) 0.76
Pharmacokinetics of new nootropic acylprolyldipeptide and its penetration across the blood-brain barrier after oral administration. Bull Exp Biol Med (2000) 0.76
Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress. Bull Exp Biol Med (2000) 0.76
[Effect of sodium hydroxybutyrate on the ammonia level in the rat muscles under physical exercise]. Biull Eksp Biol Med (1980) 0.76
[Multicomponent antithrombotic effect of the neuroprotective prolyl dipeptide GVS-111 and its major metabolite cyclo-L-prolylglycine]. Eksp Klin Farmakol (2002) 0.76
Original Nerve Growth Factor Mimetic Dipeptide GK-2 Restores Impaired Cognitive Functions in Rat Models of Alzheimer's Disease. Acta Naturae (2013) 0.76
GABA-opiates interactions in the activity of analgesics. Arch Int Pharmacodyn Ther (1983) 0.75
Nootropic compound L-pyroglutamyl-D-alanine-amide restores hippocampal long-term potentiation impaired by exposure to ethanol in rats. Neurosci Lett (1995) 0.75
[Combined action of caffeine and sydnocarb]. Biull Eksp Biol Med (1983) 0.75
[New evidence for a GABA-ergic component in the mechanism of action of benzodiazepine tranquilizers]. Biull Eksp Biol Med (1981) 0.75
[Effect of sodium oxybutyrate on oxidative processes in the brain]. Farmakol Toksikol (1971) 0.75
[Effect of several tropane derivatives on noradrenaline absorption by hypothalamic synaptic vesicles]. Biull Eksp Biol Med (1976) 0.75
[Modern pharmacotherapy of cardiovascular diseases]. Vestn Akad Med Nauk SSSR (1970) 0.75
[Effect of motropin and naloxone on electroacupuncture analgesia]. Biull Eksp Biol Med (1981) 0.75
[Intracellular mechanism of the action of imipramine and diazepam]. Biull Eksp Biol Med (1975) 0.75
[Necessity for simplifying the writing of prescriptions]. Farmatsiia (1975) 0.75
[Social aspects of modern pharmacology]. Farmakol Toksikol (1983) 0.75
Neuropharmacological and neurochemical approaches to preclinical evaluation of neuroleptics. Adv Biochem Psychopharmacol (1980) 0.75
[Pharmacology of ethacizin]. Farmakol Toksikol (1986) 0.75
[Antiarrhythmic effectiveness of 3-carbalkoxyamino-5-(omega-aminoacyl)-10,11-dihydro-5H-dibenz-[b,f]- azepines]. Pharmazie (1985) 0.75
[A new group of anti-arrhythmia agents (the search, results and concept)]. Farmakol Toksikol (1990) 0.75
[Deontological problems in pharmacology]. Farmakol Toksikol (1982) 0.75
[Mechanism of the central effects of tropane]. Farmakol Toksikol (1982) 0.75
[The basic pharmacologic properties of several 2-substituted tryptamines]. Biull Eksp Biol Med (1967) 0.75
[Classification and use of psychotropic agents]. Klin Med (Mosk) (1976) 0.75
The effect of motropine and of some neuropeptides on opiate receptors. Ann Ist Super Sanita (1982) 0.75
[Pharmacology of uxepam]. Farmakol Toksikol (1984) 0.75
[Effect of iproniazid on the tremor caused by some 2-substituted derivatives of tryptamine]. Farmakol Toksikol (1968) 0.75
Electrophysiological evidence for an inhibitory action of diazepam upon cat brain cortex. Arch Int Pharmacodyn Ther (1975) 0.75
[Principles of clinical pharmacology]. Ter Arkh (1974) 0.75
[Morphine-like activity of the enkephalin analog Tyr-D-Ala-Gly-Phe-NH2]. Biull Eksp Biol Med (1981) 0.75
Effect of trifluoperazine, carbidine, and imipramine on evoked potentials in structures of the limbico-reticular complex. Bull Exp Biol Med (1974) 0.75
[The effect tranquilizers and antidepressants on the summation of impulses of different modalities]. Biull Eksp Biol Med (1973) 0.75
[Effect of cocaine on the tyrosine hydroxylase of rat hypothalamus]. Biull Eksp Biol Med (1976) 0.75
[Effect of neuroleptics of phenothiazine series on the summation of impulses in central nervous system]. Farmakol Toksikol (1970) 0.75
[Design of the novel dipeptide neuropsychotropic drug preparations]. Eksp Klin Farmakol (2003) 0.75
[Effect of tranquilizing and antidepressive agents on the summation of impulses in the central nervous system]. Farmakol Toksikol (1971) 0.75
[Tropane ligands of different types of opiate receptors]. Farmakol Toksikol (1983) 0.75
[Effect of piracetam derivatives on antibody formation]. Biull Eksp Biol Med (1985) 0.75
[Anti-arrhythmia properties of pyromecaine]. Farmakol Toksikol (1983) 0.75
[Effect of sodium oxybutyrate on the action of anesthetics]. Farmakol Toksikol (1968) 0.75
[The relationship between the chemical structure and anti-arrhythmia action of a number of omega-aminoacyl-3-carbalcoxyaminodibenzazepines]. Farmakol Toksikol (1990) 0.75
[Pharmacology at the Academy of Medical Sciences of the USSR]. Farmakol Toksikol (1984) 0.75
[The anti-arrhythmic activity of the arylamides of alpha-hexamethyleneiminocarboxylic acids]. Farmakol Toksikol (1991) 0.75
Participation of GABA in the mechanism of action of psychotropic agents. Acta Physiol Pharmacol Bulg (1982) 0.75
[Relation of the structure, rate of hydrolysis and activity of dicarboxylic acid esters]. Farmakol Toksikol (1989) 0.75
[Pharmacologic effect on the adrenergic mechanisms of heart blood supply regulation]. Kardiologiia (1967) 0.75
[Pharmacology of thyroliberin]. Biull Eksp Biol Med (1983) 0.75
[GABA-ergic component in the mechanism of action of narcotic analgesics and enkephalin analogs]. Vestn Akad Med Nauk SSSR (1982) 0.75
[Effect of tropane on the cholinoreceptors of the cerebral cortex]. Biull Eksp Biol Med (1984) 0.75
[Antagonism of 5-oxytryptophan to aminazin and triftazin (according to EEG data)]. Biull Eksp Biol Med (1966) 0.75
[Effect of prostaglandins, cyclic nucleotides and ions on the analgesic effect of enkephalin analogs]. Biull Eksp Biol Med (1982) 0.75
[The effect of sodium hydroxybutyrate on cerebral tissue oxidative processes in hypoxia]. Biull Eksp Biol Med (1970) 0.75
[Mediators in the mechanism of the neurotropic action of thyroliberin]. Biull Eksp Biol Med (1984) 0.75
[The effect of cocaine on the central action of noradrenaline]. Biull Eksp Biol Med (1975) 0.75
[New class of narcotic analgesic antagonists]. Vestn Akad Med Nauk SSSR (1980) 0.75
[N. P. Krakov. (On the centenary of his birth)]. Klin Med (Mosk) (1965) 0.75